1 – 89 of 89
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Factor IX antibodies and tolerance in hemophilia B in the Nordic countries - The impact of F9 variants and complications
(
- Contribution to journal › Article
-
Mark
Associations between hemostatic markers and mortality in COVID-19 - Compounding effects of D-dimer, antithrombin and PAP complex
(
- Contribution to journal › Article
- 2020
-
Mark
Continued benefit demonstrated with BAY 81-8973 prophylaxis in previously treated children with severe haemophilia A : Interim analysis from the LEOPOLD Kids extension study
(
- Contribution to journal › Article
- 2017
-
Mark
Pre- and post-test probabilities of venous thromboembolism and diagnostic accuracy of D-dimer, estimated by European clinicians working in emergency departments
(
- Contribution to journal › Article
- 2016
-
Mark
Antithrombotic therapy in patients with non-valvular atrial fibrillation in Southern Sweden: A population-based cohort study.
(
- Contribution to journal › Article
- 2015
-
Mark
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.
(
- Contribution to journal › Article
-
Mark
Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden.
(
- Contribution to journal › Article
-
Mark
INR variability and outcomes in patients with mechanical heart valve prosthesis.
(
- Contribution to journal › Article
-
Mark
Tranexamic acid - an old drug still going strong and making a revival.
(
- Contribution to journal › Scientific review
-
Mark
Warfarin persistence among stroke patients with atrial fibrillation.
(
- Contribution to journal › Article
-
Mark
Family history of venous thromboembolism and risk of hospitalized thromboembolism in cancer patients: A nationwide family study.
(
- Contribution to journal › Article
-
Mark
Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.
(
- Contribution to journal › Article
-
Mark
Warfarin treatment complications do not correlate to cTTR when above 70.
(
- Contribution to journal › Article
-
Mark
Comparison of automated von Willebrand factor activity assays.
2015) In Thrombosis Research(
- Contribution to journal › Article
-
Mark
More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate
(
- Contribution to journal › Article
- 2014
-
Mark
Outcome after thrombolysis for occluded endoprosthesis, bypasses and native arteries in patients with lower limb ischemia.
(
- Contribution to journal › Article
-
Mark
Mechanical heart valve prosthesis and warfarin - Treatment quality and prognosis.
(
- Contribution to journal › Article
-
Mark
Thromboembolism, major bleeding and mortality in patients with mechanical heart valves- a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism.
(
- Contribution to journal › Article
-
Mark
Glycosaminoglycans in cancer treatment.
(
- Contribution to journal › Article
-
Mark
Low degree of shared genetic susceptibility to coronary artery disease and venous thromboembolism.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The association between red cell distribution width and venous thromboembolism: A biochemical evaluation
(
- Contribution to journal › Letter
-
Mark
The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study.
(
- Contribution to journal › Article
-
Mark
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
(
- Contribution to journal › Article
-
Mark
Joint disease, the hallmark of haemophilia: What issues and challenges remain despite the development of effective therapies?
(
- Contribution to journal › Scientific review
-
Mark
Targeting exosites of activated protein C as therapeutic possibility?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Red cell distribution width and risk for venous thromboembolism: A population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
(
- Contribution to journal › Article
-
Mark
A comprehensive study of ovine haemostasis to assess suitability to model human coagulation
(
- Contribution to journal › Article
- 2013
-
Mark
Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses
(
- Contribution to journal › Article
-
Mark
Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin.
(
- Contribution to journal › Article
-
Mark
Dabigatran in clinical practice - One-year experience at Skåne University Hospital.
(
- Contribution to journal › Letter
-
Mark
Association between variation in ADAMTS13 and aneurysmal subarachnoid hemorrhage
(
- Contribution to journal › Letter
-
Mark
Time trends in pulmonary embolism: A matter of age and gender.
(
- Contribution to journal › Debate/Note/Editorial
- 2012
-
Mark
TFPI gene variation and ischemic stroke
(
- Contribution to journal › Letter
-
Mark
The APC-PCI concentration as an early marker of activation of blood coagulation A study of women on combined oral contraceptives
(
- Contribution to journal › Article
-
Mark
Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
(
- Contribution to journal › Article
-
Mark
A nationwide family study of pulmonary embolism: Identification of high risk families with increased risk of hospitalized and fatal pulmonary embolism.
(
- Contribution to journal › Article
-
Mark
Socioeconomic and occupational risk factors for venous thromboembolism in Sweden: A nationwide epidemiological study.
(
- Contribution to journal › Article
-
Mark
The value of tomographic ventilation/perfusion scintigraphy (V/PSPECT) for follow-up and prediction of recurrence in pulmonary embolism.
2012) In Thrombosis Research(
- Contribution to journal › Article
- 2011
-
Mark
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy
(
- Contribution to journal › Article
-
Mark
Immune tolerance induction in patients with hemophilia A
(
- Contribution to journal › Article
-
Mark
Glomerular filtration rate in patients with atrial fibrillation on warfarin treatment: A subgroup analysis from the AURICULA registry in Sweden.
(
- Contribution to journal › Article
-
Mark
Familial risk factors shared by venous thromboembolism and cancer: A nationwide epidemiological study of Swedish families.
(
- Contribution to journal › Article
- 2010
-
Mark
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD
(
- Contribution to journal › Article
-
Mark
Treatment of the critically ill patient with protein C: Is it worth the cost?
(
- Contribution to journal › Article
-
Mark
Uncarboxylated matrix Gla-protein (ucMGP) and osteocalcin (ucOC) increase postoperatively after major abdominal cancer and orthopedic surgery
2010) 5th International Conference on Thrombosis and Hemostasis Issues in Cancer In Thrombosis Research 125(Suppl. 2). p.178-178(
- Contribution to journal › Published meeting abstract
-
Mark
Retrospective analysis of coagulation parameters at epidural anaesthesia catheter withdrawal after esophageal resection
2010) 5th International Conference on Thrombosis and Hemostasis Issues in Cancer In Thrombosis Research 125(Suppl. 2). p.177-178(
- Contribution to journal › Published meeting abstract
-
Mark
Tissue factor phosphorylation requires protease activated receptor-2 expression: Correlation with the prognosis of human breast cancer
2010) 5th International Conference on Thrombosis and Hemostasis Issues in Cancer In Thrombosis Research 125. p.164-164(
- Contribution to journal › Published meeting abstract
-
Mark
Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality.
(
- Contribution to journal › Article
-
Mark
A Cost-effectiveness Analysis of Diagnostic Algorithms of Deep Vein Thrombosis at the Emergency Department.
(
- Contribution to journal › Article
-
Mark
Anti-prothrombin antibodies are associated with thrombosis in children.
(
- Contribution to journal › Article
-
Mark
Coagulation activation and ultrasound characteristics in patients with carotid artery disease.
(
- Contribution to journal › Article
-
Mark
History of rFVIIa therapy.
(
- Contribution to journal › Article
- 2009
-
Mark
Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS).
(
- Contribution to journal › Article
-
Mark
Thrombin generation after emergency contraception
2009) 3rd International Symposium on Womens Health Issues in Thrombosis and Haemostasis In Thrombosis Research 123. p.152-152(
- Contribution to journal › Published meeting abstract
-
Mark
Increased thrombin generation in women with a history of preeclampsia
(
- Contribution to journal › Article
-
Mark
Performance of two relatively new quantitative D-dimer assays (Innovance D-dimer and AxSYM D-dimer) for the exclusion of deep vein thrombosis.
(
- Contribution to journal › Article
-
Mark
Clinical probability assessment and D-dimer determination in patients with suspected deep vein thrombosis, a prospective multicenter management study.
(
- Contribution to journal › Article
-
Mark
Haemate P/Humate-P: a systematic review.
(
- Contribution to journal › Article
-
Mark
Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
(
- Contribution to journal › Article
- 2008
-
Mark
Gene expression profiling for the identification of G-protein coupled receptors in human platelets
(
- Contribution to journal › Article
- 2007
-
Mark
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers
(
- Contribution to journal › Article
-
Mark
Von Willebrand: The scientist, the disease, the factor, and the treatment
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Erik von Willebrand.
(
- Contribution to journal › Article
-
Mark
Antithrombotic and anticoagulant effects of wild type and Gla-domain mutated human activated protein C in rats.
(
- Contribution to journal › Article
-
Mark
Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
(
- Contribution to journal › Article
-
Mark
The APC-PCI complex concentration predicts outcome of aortic surgery.
(
- Contribution to journal › Article
- 2006
-
Mark
The need for prophylaxis in von Willebrand's disease and other coagulation disorders
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Early identification of acute myocardial infarction by activated protein C-protein C inhibitor complex.
(
- Contribution to journal › Article
-
Mark
The von Willebrand Disease Prophylaxis Network (vWD PN): Exploring a treatment concept.
(
- Contribution to journal › Article
-
Mark
Low-energy ultrasound exposure of the streptokinase molecule may enhance but also attenuate its fibrinolytic properties.
(
- Contribution to journal › Article
- 2005
-
Mark
Protein C levels can be forecasted by global haemostatic tests in critically ill patients and predict long-term survival.
(
- Contribution to journal › Article
- 2004
-
Mark
Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
(
- Contribution to journal › Article
-
Mark
Genetic variation in the human thrombomodulin promoter locus and prognosis after acute coronary syndrome.
(
- Contribution to journal › Article
- 2003
-
Mark
Mutations within the cyclooxygenase-1 gene in aspirin non-responders with recurrence of stroke.
(
- Contribution to journal › Article
- 2002
-
Mark
Association of prothrombin and protein S with plasma triglyceride-rich lipoproteins in humans after test meals rich in milk fat or soybean oil.
(
- Contribution to journal › Article
-
Mark
Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis
(
- Contribution to journal › Article
- 2001
-
Mark
Anti- and procoagulant activities in factor VII-deficient subjects
(
- Contribution to journal › Article
- 2000
-
Mark
Correlation between different intensities of anti-vitamin K treatment and coagulation parameters
(
- Contribution to journal › Article
- 1999
-
Mark
Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin
(
- Contribution to journal › Article
- 1997
-
Mark
The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man
(
- Contribution to journal › Article
- 1996
-
Mark
Catabolism of prothrombin-chylomicron complexes in vivo in the rat
(
- Contribution to journal › Article
- 1995
-
Mark
Binding of prothrombin to chyle chylomicrons: effects of temperatuure and calcium ions, and role of surface phospholipids.
(
- Contribution to journal › Article
- 1993
-
Mark
Effect of unfragmented heparin alone and in combination with dextran on experimental venous thrombosis in rabbits
(
- Contribution to journal › Article
- 1992
-
Mark
Effect on primary haemostasis of prophylactic regimens of low molecular weight heparin, unfractionated heparin, dextran and their combinations. An animal experimental study
(
- Contribution to journal › Article
- 1991
-
Mark
Pharmacokinetics of a low molecular weight heparin, logiparin, after intravenous and subcutaneous administration to healthy volunteers
(
- Contribution to journal › Article
- 1989
-
Mark
Influence of a low molecular weight heparin on the inhibition of factor Xa and thrombin in hip surgery
(
- Contribution to journal › Article
- 1987
-
Mark
Plasma lipolytic activity after subcutaneous administration of heparin and a low molecular weight heparin fragment
(
- Contribution to journal › Article